Literature DB >> 2969055

The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.

K Ozawa1, J Ayub, S Kajigaya, T Shimada, N Young.   

Abstract

The B19 parvovirus is a cause of bone marrow failure in humans. B19 is toxic to erythroid progenitor cells in vitro. Viral products possibly responsible for toxicity were explored by transfection of cloned B19 genome into HeLa cells. The nonstructural (NS) protein was detected in cells 30 h after transfection. Plasmids containing the B19 genome were transfected with selectable marker genes in stable transformation assays. Plasmids that contained the left side of the B19 genome, which encodes the NS protein of the virus, inhibited antibiotic-resistant colony formation. Transformation occurred when NS protein expression was blocked by mutation. Suppression of transformation by NS protein was not tissue specific, suggesting a role for NS protein in toxicity for nonpermissive cells without parvovirus replication or virion accumulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969055      PMCID: PMC253725     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Chronic bone marrow failure due to persistent B19 parvovirus infection.

Authors:  G J Kurtzman; K Ozawa; B Cohen; G Hanson; R Oseas; N S Young
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

2.  Construction of a genetic switch for inducible trans-activation of gene expression in eucaryotic cells.

Authors:  S L Rhode
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  trans-Activation of parvovirus P38 promoter by the 76K noncapsid protein.

Authors:  S L Rhode
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

4.  Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes.

Authors:  M A Labow; L H Graf; K I Berns
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

5.  Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia.

Authors:  U M Saarinen; T L Chorba; P Tattersall; N S Young; L J Anderson; E Palmer; P F Coccia
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

6.  Positive and negative autoregulation of the adeno-associated virus type 2 genome.

Authors:  M A Labow; P L Hermonat; K I Berns
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

7.  Novel transcription map for the B19 (human) pathogenic parvovirus.

Authors:  K Ozawa; J Ayub; Y S Hao; G Kurtzman; T Shimada; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures.

Authors:  K Ozawa; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

9.  Replication of the B19 parvovirus in human bone marrow cell cultures.

Authors:  K Ozawa; G Kurtzman; N Young
Journal:  Science       Date:  1986-08-22       Impact factor: 47.728

10.  Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product.

Authors:  J D Tratschin; J Tal; B J Carter
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

View more
  64 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Characterization of the gene expression profile of human bocavirus.

Authors:  Aaron Yun Chen; Fang Cheng; Sai Lou; Yong Luo; Zhengwen Liu; Eric Delwart; David Pintel; Jianming Qiu
Journal:  Virology       Date:  2010-05-10       Impact factor: 3.616

3.  A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.

Authors:  J M Liu; S W Green; T Shimada; N S Young
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 4.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

5.  The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.

Authors:  Susanne I Lang; Stephanie Boelz; Alexandra Y Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Jan J Cornelis
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.

Authors:  M Momoeda; S Wong; M Kawase; N S Young; S Kajigaya
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Authors:  Yong Luo; Steve Kleiboeker; Xuefeng Deng; Jianming Qiu
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins.

Authors:  Q Yang; F Chen; J P Trempe
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation.

Authors:  Kenji Abe; Tetsuya Kiuchi; Koichi Tanaka; Yoshihiro Edamoto; Naoto Aiba; Tetsutaro Sata
Journal:  Int J Med Sci       Date:  2007-04-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.